Evusheld protects the vulnerable from Covid. Why are so few using it?
The drug was approved eight months ago as the best safeguard for immunocompromised patients. But the word does not seem to have spread far.
Source: statnews.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Ryan Roux. Real-time updates on events, politics, business and more.